AAAAAA

   
Results: 1-25 | 26-50 | 51-57 |
Results: 51-57/57
A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct
Authors: ten Bosch, GJA Kessler, JH Joosten, AM Bres-Vloemans, AA Geluk, A Godthelp, BC van Bergen, J Melief, CJM Leeksma, OC
Citation: Gja. Ten Bosch et al., A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct, BLOOD, 94(3), 1999, pp. 1038-1045
T-cell-mediated immunotherapy of cancer
Authors: Offringa, R Toes, REM Ressing, ME de Bruijn, MLH Melief, CJM
Citation: R. Offringa et al., T-cell-mediated immunotherapy of cancer, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 447-461
CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity
Authors: Toes, REM Schoenberger, SP van der Voort, EIH Offringa, R Melief, CJM
Citation: Rem. Toes et al., CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity, SEMIN IMMUN, 10(6), 1998, pp. 443-448
Identification of antigens recognized by T lymphocytes on human tumours, and pilot vaccination studies with defined antigens
Authors: Boon, T Parmiani, G Cerottini, JC Coulie, P Melief, CJM Wolfel, T Rammensee, HG
Citation: T. Boon et al., Identification of antigens recognized by T lymphocytes on human tumours, and pilot vaccination studies with defined antigens, BIOM HLTH R, 24, 1998, pp. 3-12
Preclinical evaluation of two tumour associated antigens as potential immunogens for the immunotherapy of breast and ovarian cancer
Authors: Taylor-Papadimitrou, J Bodmer, W Melief, CJM Hilgers, J Real, FX Nuti, M Hanski, C
Citation: J. Taylor-papadimitrou et al., Preclinical evaluation of two tumour associated antigens as potential immunogens for the immunotherapy of breast and ovarian cancer, BIOM HLTH R, 24, 1998, pp. 107-111
BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylation
Authors: ten Bosch, GJA Kessler, JH Blom, J Joosten, AM Gambacorti-Passerini, C Melief, CJM Leeksma, OC
Citation: Gja. Ten Bosch et al., BCR-ABL oncoprotein is expressed by platelets from CML patients and associated with a special pattern of CrkL phosphorylation, BR J HAEM, 103(4), 1998, pp. 1109-1115
Antitumor vaccination using peptide-based vaccines
Authors: Offringa, R Toes, REM Ressing, ME Vierboom, MPM Ossendorp, F Van der Burg, SH Nijman, HW Kast, WM Melief, CJM
Citation: R. Offringa et al., Antitumor vaccination using peptide-based vaccines, RESEARCH IN, 1998, pp. 205-215
Risultati: 1-25 | 26-50 | 51-57 |